A carregar...

Treatment adherence in tyrosinemia type 1 patients

BACKGROUND: While therapeutic advances have significantly improved the prognosis of patients with hereditary tyrosinemia type 1 (HT1), adherence to dietary and pharmacological treatments is essential for an optimal clinical outcome. Poor treatment adherence is well documented among patients with chr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: González-Lamuño, Domingo, Sánchez-Pintos, Paula, Andrade, Fernando, Couce, María L., Aldámiz-Echevarría, Luís
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8173906/
https://ncbi.nlm.nih.gov/pubmed/34082789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01879-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!